超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

德國Evotec
藥物發(fā)現(xiàn)和開發(fā)的制藥和生物技術公司的合作伙伴
Evotec是在發(fā)現(xiàn)和創(chuàng)新的小分子藥物開發(fā)的領導者.本公司已建立了一個強大的平臺，適用于所有的目標治療領域，并在中樞神經(jīng)系統(tǒng)(CNS)的地方，是建立合作的候選藥物管道有關的疾病領域的專門知識.通過研究合作與Evotec提供最高質量的研究成果，其合作伙伴在專利項目的制藥和生物技術行業(yè).
 


制藥和生物技術公司的首要藥物發(fā)現(xiàn)和開發(fā)伙伴
Evotec是發(fā)現(xiàn)和開發(fā)新型小分子藥物的領先者。該公司建立了一個強大的平臺，適用于所有治療領域的目標，并在中樞神經(jīng)系統(tǒng)(CNS)相關疾病領域擁有特定的專門知識，該公司正在建立一條用于合作的候選藥物管道。通過研究合作和專利項目，Evotec正在向制藥和生物技術行業(yè)的合作伙伴提供最高質量的研究成果。

Proprietary CNS pipeline
Evotec's proprietary projects specialize in finding new treatments for diseases of the Central Nervous System (CNS). The focus of research is on major CNS related conditions, including sleep disorders, Alzheimer's disease, pain management and smoking cessation - fast growing therapeutic areas with large unmet medical needs. Evotec has a diverse product pipeline with candidates at various stages of development. The Company's most advanced product candidate, which has recently completed Phase II clinical trials with excellent results, is EVT 201, a partial positive allosteric modulator of the GABAA receptor complex for the treatment of insomnia. Through selective in-licensing and the use of its platform for internal discovery efforts, Evotec intends to further develop and expand its preclinical and clinical CNS pipeline for partnering.

Research collaborations
In research collaborations, Evotec has established itself as the partner of choice for pharmaceutical and biotechnology companies worldwide by providing high quality, innovative and integrated solutions from drug target to clinic through an unmatched range of capabilities, including assay development, high-throughput and high-content screening, fragment-based drug discovery and medicinal chemistry. Applying its proven expertise in close collaboration with customers, Evotec is committed to delivering the highest levels of research and can quote outstanding references with the names of the world's leading pharmaceutical and biotechnology companies appearing among its many partners. To fully exploit the potential of its capabilities, Evotec increasingly complements its traditional fee-for-service business with higher value, results-driven projects in core areas by sharing in the customer's risk and success through significant milestone payments and royalties.

Evotec is a high performance organization that manages for innovation and efficiency across all areas. We aim to recruit, train, motivate and retain premier talent and to support our partners through the partnering of preclinical and clinical assets as well as results-orientated, highly collaborative relationships, creating innovative solutions using outstanding capabilities and thought leadership.